The so-called Solidarity trial, which aims to test additional treatment options, will be organised by Santara Clinics, with other hospitals across the country joining in the future.
“Lithuania’s patients will have a unique opportunity to take part in an international trial, which aims to study both the existing treatments used for other diseases and innovative drugs,” said Laimonas Griškevičius from Santara Clinics. People admitted to hospital with Covid-19 will be asked to participate voluntarily, before being chosen for one of the available study options, according to WHO guidelines.
Patients are currently provided only with symptomatic treatment, as there is no approved treatment against the novel coronavirus, according to Santara Clinics. The Solidarity trial had already begun in Spain and Norway. The trial aims to discover whether any drug slows disease progression or improves survival, according to WHO. Over 70 countries confirmed they will contribute to the trial, with many others in the process of joining, WHO said in late March.